Meeder Asset Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-453
Closed -$27.1K 878
2025
Q2
$27.1K Hold
453
﹤0.01% 464
2025
Q1
$23.8K Hold
453
﹤0.01% 510
2024
Q4
$24.9K Hold
453
﹤0.01% 484
2024
Q3
$22.8K Hold
453
﹤0.01% 471
2024
Q2
$19.9K Buy
+453
New +$19.3K ﹤0.01% 519
2019
Q1
Sell
-17
Closed 1772
2018
Q4
$0 Buy
+17
New +$457 ﹤0.01% 1752
2017
Q2
Sell
-330
Closed -$3K 1765
2017
Q1
$3K Sell
330
-549
-62% -$5.09K ﹤0.01% 1263
2016
Q4
$10K Buy
+879
New +$9.46K ﹤0.01% 756

Other funds holding IRMD

Meeder Asset Management's IRMD Position: Q3 2025 in Review

Meeder Asset Management sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 453 shares — an estimated $27.1K sold.

Meeder Asset Management first reported a position in IRMD in Q4 2016 and held it in 8 quarters. The position peaked at $27.1K in Q2 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Meeder Asset Management reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
  • Meeder Asset Management sold 453 iRadimed shares in Q3 2025, an estimated $27.1K.
  • Meeder Asset Management first reported a position in iRadimed in Q4 2016 and held it in 8 quarters.
  • Meeder Asset Management's iRadimed position peaked at $27.1K in Q2 2025.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Meeder Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.